Know Your Investor (April Edition): OrbiMed Advisors

Shots: An American investment firm, OrbiMed Advisor is a prominent name when it comes to healthcare investments. The company boasts a robust portfolio of more than 180 companies, including AbCellera, Acelyrin, Actus Medical, and Adaptive Biotechnologies, among others In 2023, OrbiMed invested in 38 funding rounds; 11, 6, 9 & 12 every quarter across 2023…

ByPrince GiriApril 24, 2024

TOP 20

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Shots: Sticking to M&A and licensing agreements can be really challenging, especially when dealing with stringent antitrust laws and evolving regulatory challenges. In such adverse scenarios, the rational and right step seems to be nullifying the existing deals. In 2023, the termination of the deal between Janssen and Arrowhead remained the talk of the town…

ByPrince GiriApril 18, 2024

TOP 20

Top 20 Biopharma Companies of 2024

Shots: Driven by innovations and propelled by the pursuit of delivering the best-in-class therapies, 2023 remained a good year for the Biopharma Industry, despite a slight revenue decline, partly due to the conclusion of the COVID-19 pandemic With a CAGR of 7.8 %, the global biopharma industry is anticipated to register a market size of…

ByPrince GiriApril 11, 2024

TOP 20

Top 20 IPOs in Healthcare by Total Fund Value 2023

Shots: Clinical-stage biopharma companies are in constant need of funding and the best way to pull in money in such dire situations is by going public. 2023 had been a great year for Wall Streets across the globe with continuous announcements of IPOs Kenvue by bagging $4.37B upon completion of its IPO ranked first in…

ByPrince GiriMarch 28, 2024

TOP 20

Top 20 Women Health Focusing Companies of 2024 Based on Market Cap

Shots: While the World celebrated International Women’s Day, PharmaShots was busy preparing an exciting report on the Top 20 Women Health Focusing Companies Based on Market Cap Women's Health Market size was valued at $38.10B in 2023 and is expected to register $58.10B by 2030 with a CAGR of 4.9 percent. AbbVie managed to secure…

ByPrince GiriMarch 14, 2024

TOP 20

Top 20 Radiopharma Companies of 2024 Based on Market Cap

Shots: With diverse applications in diagnostic imaging, theragnostics, and targeted therapy, radiopharmaceuticals are gradually tapping into an ocean of unlimited opportunities By 2030, the radiopharmaceutical market size is expected to grow to $12.18B. In 2023, POINT Biopharma topped the list among radiopharma companies with a market cap of $726.88B followed by Novartis with a market…

ByPrince GiriFebruary 28, 2024

TOP 20

Top 20 Life Sciences Deals of 2023 by Total Deal Value

Shots: Driven by mutual growth and expansion, strategic collaborations are embedded deeply in the modus operandi of life sciences deals. In 2023, the volume of life science deals was comparatively high vs. 2022 The collaboration deal between Daiichi Sankyo and Merck & Co. for $22B ranks first in our list followed by the development and…

ByPrince GiriFebruary 15, 2024

TOP 20

Top 20 Biopharma M&A of 2023 by Total Deal Value

Shots: With stringent antitrust regulation clasping the overall volume of M&A deals, the biopharma industry manages to hold up a few strong M&A while conquering the waves of unexpected economic turmoil in 2023 In 2023, the global biopharma industry witnessed an astounding transformation with M&A deals. Pfizer’s acquisition of Seagen for $43B ranks first in…

ByPrince GiriJanuary 24, 2024

TOP 20

Top 20 Animal Health Companies Based on 2022 Total Revenue

Shots: The animal health industry is involved in a wide variety of services, from disease prevention to addressing insatiable nutritional needs. This sector not only protects us from potential zoonotic diseases but also delivers food of high quality derived from animals In 2022, the animal health industry was valued at $58.66B. By 2030, the global animal health…

ByPrince GiriDecember 14, 2023

TOP 20

20 Contract Development and Manufacturing Organizations (CDMOs) of 2022

Shots: Over the years, CDMOs have significantly transformed the course of pharmaceutical and biopharmaceutical companies by leveraging their flexible manufacturing facilities and on-time drug deliveries CDMOs help meet the ever-evolving needs of the healthcare sector by fostering the use of new-age technologies and advanced drug development and manufacturing processes PharmaShots brings a condensed report on 20 Contract…

ByPrince GiriDecember 5, 2023

Prince Giri

Know Your Investor (April Edition): OrbiMed Advisors

Top 20 Biopharma Deal Terminations of 2023 Based on Total Deal Value

Top 20 Biopharma Companies of 2024

Top 20 IPOs in Healthcare by Total Fund Value 2023

Top 20 Women Health Focusing Companies of 2024 Based on Market Cap

Top 20 Radiopharma Companies of 2024 Based on Market Cap

Top 20 Life Sciences Deals of 2023 by Total Deal Value

Top 20 Biopharma M&A of 2023 by Total Deal Value

Top 20 Animal Health Companies Based on 2022 Total Revenue

20 Contract Development and Manufacturing Organizations (CDMOs) of 2022

Contact US

OUR INFORMATION

FOLLOW US